Serum fibroblast growth factor-23 levels in chronic haemodialysis patients

被引：0
|
作者：
Salwa Ibrahim
Laila Rashed
机构：
[1] Cairo University,Department of Medicine
[2] Cairo University,Department of Biochemistry
来源：
International Urology and Nephrology | 2009年 / 41卷
关键词：
Fibroblast growth factor 23; Hemodialysis; Hyperparathyroidism; Hyperphosphataemia; End-stage renal disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：163 / 169
页数：6
相关论文
共 50 条
  • [41] Effects of lanthanum carbonate and calcium carbonate on fibroblast growth factor 23 and hepcidin levels in chronic hemodialysis patients
    Chang, Yu-Ming
    Tsai, Shih-Ching
    Shiao, Chih-Chung
    Liou, Hung-Hsiang
    Yang, Chuan-Lan
    Tung, Nai-Yu
    Hsu, Kua-Sui
    Chen, I-Ling
    Liu, Mei-Chyn
    Kao, Jsun-Liang
    Jhen, Rong-Na
    Huang, Ya-Ting
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2017, 21 (05) : 908 - 916
  • [42] Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients
    M. Inaba
    S. Okuno
    Y. Imanishi
    S. Yamada
    A. Shioi
    T. Yamakawa
    E. Ishimura
    Y. Nishizawa
    Osteoporosis International, 2006, 17 : 1506 - 1513
  • [43] Effects of lanthanum carbonate and calcium carbonate on fibroblast growth factor 23 and hepcidin levels in chronic hemodialysis patients
    Yu-Ming Chang
    Shih-Ching Tsai
    Chih-Chung Shiao
    Hung-Hsiang Liou
    Chuan-Lan Yang
    Nai-Yu Tung
    Kua-Sui Hsu
    I-Ling Chen
    Mei-Chyn Liu
    Jsun-Liang Kao
    Rong-Na Jhen
    Ya-Ting Huang
    Clinical and Experimental Nephrology, 2017, 21 : 908 - 916
  • [44] Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients
    Inaba, M.
    Okuno, S.
    Imanishi, Y.
    Yamada, S.
    Shioi, A.
    Yamakawa, T.
    Ishimura, E.
    Nishizawa, Y.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 (10) : 1506 - 1513
  • [45] Fibroblast growth factor-23 may serve as a novel biomarker for renal osteodystrophy progression
    Liu, Si Yan
    Zhang, Dong Dong
    Wu, Yang Fang
    Luo, Huang Huang
    Jiang, Guang Mei
    Xu, Yao
    Wu, Yue
    Xia, Xun
    Wei, Wei
    Hu, Bo
    Hu, Peng
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2019, 43 (01) : 535 - 546
  • [46] Effect of Sucroferric Oxyhydroxide on Fibroblast Growth Factor 23 Levels in Hemodialysis Patients
    Otsuki, Tomoyasu
    Utsunomiya, Kei
    Moriuchi, Masari
    Horikoshi, Shu
    Okamura, Masahiro
    Suzuki, Hiroko
    Okamura, Makiyo
    Maruyama, Noriaki
    Shibahara, Nami
    Abe, Masanori
    NEPHRON, 2018, 140 (03) : 161 - 168
  • [47] Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients
    Torres, P. Urena
    Friedlander, G.
    de Vernejoul, M. C.
    Silve, C.
    Prie, D.
    KIDNEY INTERNATIONAL, 2008, 73 (01) : 102 - 107
  • [48] Radiographic Assessment of Vascular Calcification, Aortic Pulse Wave Velocity, Ankle-Brachial Index and Fibroblast Growth Factor-23 in Chronic Hemodialysis Patients
    Breznik, Silva
    Ekart, Robert
    Hren, Martin
    Rupreht, Mitja
    Balon, Breda Pecovnik
    THERAPEUTIC APHERESIS AND DIALYSIS, 2013, 17 (04) : 378 - 383
  • [49] Association of serum fibroblast growth factor 21 levels with skeletal muscle mass and mortality in chronic hemodialysis patients
    Chiu, Liang-Te
    Wang, Chih-Hsien
    Lin, Yu-Li
    Hsu, Bang-Gee
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 (12) : 2481 - 2489
  • [50] Predictive value of circulating fibroblast growth factor-23 and Klotho on protein-energy wasting in patients undergoing hemodialysis
    Zhou, Xiaoling
    Luo, Yang
    Guo, Yidan
    Jia, Meng
    Zhang, Chunxia
    Shi, Zhihua
    Du, Ye
    FRONTIERS IN NUTRITION, 2025, 11
12345